He & She MD vs bmiMD: coaching, formats, and pricing compared
Quick verdict: He & She MD vs bmiMD differs most on bundled coaching and medication formats versus multi month pricing options. He & She MD bundles a coaching app and 1:1 clinician messaging with compounded GLP-1s; bmiMD focuses on compounded tirzepatide with multi month savings and four billing options.
See He & She MD coaching plans
Key differences at a glance: He & She MD vs bmiMD
This comparison highlights the most distinctive supported differences: medication formats and options, pricing structure and commitments, bundled coaching and clinician access, shipping and fulfillment, and regulatory disclosures. Each point below compares the two providers directly using only supplied facts.
1. Medication formats and selection
He & She MD sells compounded GLP 1 medication in three formats: semaglutide injection, oral semaglutide, and tirzepatide injection. bmiMD centers on compounded tirzepatide only. If you want semaglutide in injection or oral form, He & She MD offers those options; if you want tirzepatide with a single product focus and confirmed same price at every dose, bmiMD is the supplier documented.
2. Pricing structure and commitment
He & She MD advertises semaglutide injections starting at $139/month and oral semaglutide and tirzepatide at $199/month as six month introductory rates that renew higher after the first six months. bmiMD lists tiered multi month billing options for tirzepatide: $179 month to month, $159 for three months, $149 for six months, and $139 for a 12 month plan. bmiMD highlights lower long term monthly equivalents at longer commitments; He & She MD emphasizes six month introductory pricing that renews at the regular six month price.
3. Coaching, clinician access, and app features
He & She MD bundles a coaching app with 1:1 clinician messaging, GLP 1 specific coaching, and progress tracking included at no extra cost. bmiMD documents 24/7 clinician access and online refills and delivery, but no bundled coaching app or GLP 1 specific coaching is shown in the supplied evidence. For users prioritizing built in coaching and tracking, He & She MD is presented as the bundle; for users prioritizing clinician availability and refill convenience, bmiMD emphasizes clinician access and online refills.
Check He & She MD app and messaging
4. Shipping, refunds, and fulfillment
Both providers include free shipping in the captured evidence. He & She MD offers free expedited shipping and no membership fee. bmiMD offers free subscription shipping on every order and advertises a 100 percent refundable policy if not eligible for the program. bmiMD also notes medications are prepared in a state licensed pharmacy and independently verified in FDA and DEA registered labs as captured on its landing page.
5. Regulatory disclosures and qualifications
Both providers include the regulatory note that compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness or quality. He & She MD also states medications require consultation and prescription by a clinician through its platform and that not all customers will qualify for a prescription. bmiMD notes treatment is available only when a licensed clinician determines it is medically appropriate.
Comparison table: He & She MD vs bmiMD
| Criteria | He & She MD | bmiMD |
|---|---|---|
| Primary medications | Semaglutide injection, oral semaglutide, tirzepatide injection | Compounded tirzepatide |
| Starting price and structure | Semaglutide injections starting at $139/mo; oral semaglutide and tirzepatide at $199/mo as six month introductory rates | Tirzepatide: $179 month to month; $159 3 month; $149 6 month; $139 12 month |
| Coaching and clinician access | Coaching app with 1:1 clinician messaging and GLP 1 specific coaching included | 24/7 clinician access and online refills; no bundled coaching app documented |
| Shipping | Free expedited shipping | Free subscription shipping on every order |
| Commitment and renewal | Six month introductory rates that renew higher after first six months | Multi month plans lower long term monthly equivalent; lowest price requires 12 month commitment |
| Regulatory note | Compounded medications are not FDA approved and not reviewed by FDA | Compounded medications are not FDA approved and not reviewed by FDA |
What this means for you
If you value bundled coaching, GLP 1 specific progress tracking, and multiple medication formats including semaglutide oral or injectable, He & She MD is presented as the option that includes those features at no extra cost and promotionally lower six month introductory rates. If you value the lowest long term monthly equivalent and flexible multi month billing for tirzepatide, bmiMD documents multiple billing options down to $139/month with a 12 month plan and emphasizes free shipping and clinician access.
Start He & She MD eligibility check
Conclusion: He & She MD vs bmiMD
He & She MD vs bmiMD boils down to coaching and format variety versus multi month pricing and single product focus. He & She MD bundles a coaching app, 1:1 clinician messaging, and multiple GLP 1 formats with six month introductory rates that renew higher. bmiMD focuses on compounded tirzepatide with four billing options, free shipping, and lower long term monthly equivalents at longer commitments. Both disclose compounded medications are not FDA approved.
Choose He & She MD if you want a bundled coaching app, 1:1 clinician messaging, and access to semaglutide injection or oral semaglutide alongside tirzepatide, accepting six month introductory rates that renew higher.
Choose bmiMD if you prefer compounded tirzepatide with multiple billing terms to lower your monthly equivalent and want free subscription shipping and 24/7 clinician access, noting the lowest price requires a longer commitment.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
